Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 10 CYTK Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
May 10 CLDX Celldex Therapeutics: Rising High, With Room For Further Growth
May 10 FBIO Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
May 10 CYTK Cytokinetics First Quarter 2024 Earnings: Misses Expectations
May 9 ONCT Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript
May 9 ONCT Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05, revenue of $0.57M beats by $0.44M
May 9 ONCT Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
May 9 CYTK Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
May 9 CLDX Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
May 9 LXRX Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
May 9 CYTK Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
May 9 ICLR ICON releases its ICON Cares 2023 Report
May 9 CYTK Cytokinetics, Incorporated (CYTK) Q1 2024 Earnings Call Transcript
May 8 ONCT Oncternal Therapeutics Q1 2024 Earnings Preview
May 8 CYTK Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
May 8 CYTK Cytokinetics GAAP EPS of -$1.33 misses by $0.18, revenue of $0.84M misses by $0.07M
May 8 CYTK Cytokinetics Reports First Quarter 2024 Financial Results
May 8 CYTK Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
May 8 CYTK Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
May 8 CLDX Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags